OUTLOOK THERAPEUTICS, INC.
Income Statement
| Line Item | FY2025 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|
| Revenue | $1.4M | $8.1M | $3.1M | $3.8M | $3.0M | $5.2M |
| Cost of Revenue | $1.4M | — | — | — | — | — |
| Gross Profit | $57.2K | — | — | — | — | — |
| Gross Margin | 4.0% | — | — | — | — | — |
| Operating Expenses | ||||||
| Research & Development | $27.2M | $23.8M | $18.5M | $23.8M | $32.8M | $38.9M |
| SG&A Expense | $39.9M | $9.4M | $14.2M | $15.9M | $21.6M | $12.9M |
| Operating Income | $-67.1M | $-36.3M | $-29.6M | $-35.9M | $-51.3M | $-46.6M |
| Operating Margin | -4,744.3% | -445.6% | -960.1% | -941.4% | -1,723.3% | -892.1% |
| Interest Expense | — | $3.5M | $3.9M | $5.6M | $1.9M | $2.3M |
| Pretax Income | $-64.0M | $-37.9M | $-33.7M | $-38.3M | $-53.2M | $-48.9M |
| Income Tax Expense | $-1.6M | $-3.4M | $-3.6M | $501.5K | $103.0K | $-190.1K |
| Net Income | $-62.4M | $-34.5M | $-30.1M | $-38.8M | $-53.3M | $-47.4M |
| Net Margin | -4,416.2% | -423.8% | -974.6% | -1,019.3% | -1,788.9% | -908.1% |
| EPS (Basic) | $-1.79 | $-0.99 | $-0.61 | $-0.84 | $-1.84 | $-2.72 |
| EPS (Diluted) | $-1.79 | $-0.99 | $-0.61 | $-0.90 | $-1.84 | $-2.72 |
| Shares Outstanding (Basic) | 34.8M | 60.2M | 78.9M | 48.0M | 34.4M | 18.9M |
| Shares Outstanding (Diluted) | 34.8M | 60.2M | 78.9M | 48.1M | 34.4M | 18.9M |
| Dividends Per Share | — | — | — | — | — | — |